Last week, pharma stocks were among the worst performers on the bourses, with the NSE pharma index falling by nearly (-9.09%). The trigger was an investigation that had been launched by the US Department of Justice into generic drug companies operating in the US. According to the US department of Justice (DOJ), many of these …